Cited by 437Multiple Sclerosis Research StudiesPregnancy and Medication ImpactPsoriasis: Treatment and Pathogenesis

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Treatment of multiple sclerosis with the pregnancy hormone estriol

Sicotte, Nancy L., Liva, Stephanie M., Klutch, Rochelle, Pfeiffer, Paul, Bouvier, Seth, Odesa, Sylvia, Wu, T. C. Jackson, Voskuhl, Rhonda R.·2002·Annals of Neurology

DOI 10.1002/ana.10301

Open this paper in CoChat — free account

Abstract

Multiple sclerosis patients who become pregnant experience a significant decrease in relapses that may be mediated by a shift in immune responses from T helper 1 to T helper 2. Animal models of multiple sclerosis have shown that the pregnancy hormone, estriol, can ameliorate disease and can cause an immune shift. We treated nonpregnant female multiple sclerosis patients with the pregnancy hormone estriol in an attempt to recapitulate the beneficial effect of pregnancy. As compared with pretreatment baseline, relapsing remitting patients treated with oral estriol (8mg/day) demonstrated significant decreases in delayed type hypersensitivity responses to tetanus, interferon‐γ levels in peripheral blood mononuclear cells, and gadolinium enhancing lesion numbers and volumes on monthly cerebral magnetic resonance images. When estriol treatment was stopped, enhancing lesions increased to pretreatment levels. When estriol treatment was reinstituted, enhancing lesions again were significantly decreased. Based on these results, a larger, placebo‐controlled trial of estriol is warranted in women with relapsing remitting multiple sclerosis. This novel treatment strategy of using pregnancy doses of estriol in multiple sclerosis has relevance to other autoimmune diseases that also improve during pregnancy.

Integrity signals

Registry

Crossref · 10.1002/ana.10301

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?
Wegmann, T. G., Lin, H., Guilbert, L., & Mosmann, T. R. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90235-d · Cited by 2,852
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
Paty, D. W., Li, D. K. B., the UBC MS/MRI Study Group, & the IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.662 · Cited by 1,964
Rate of Pregnancy-Related Relapse in Multiple Sclerosis
Confavreux, C., Hutchinson, M., Hours, M. M., Cortinovis-Tourniaire, P., & Moreau, T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390501 · Cited by 1,559
Immunological Aspects Of Demyelinating Diseases
Martinꝉ, R., McFarland, H. F., & McFarlin, D. E. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.001101 · Cited by 1,021
European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis
Comi, G., Filippi, M., Wolinsky, J. S., & European/Canadian Glatiramer Acetate Study Group (2001) · Annals of Neurology · doi:10.1002/ana.64 · Cited by 768
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group.
Comi, G., Filippi, M., & Wolinsky, J. S. (2001) · PubMed · Cited by 688
Randomized controlled trial of interferon-beta-1a in secondary progressive MS
Li, D. K. B., Zhao, G., & Paty, D. W. (2001) · Neurology · doi:10.1212/wnl.56.11.1505 · Cited by 458
Glatiramer acetate (Copaxone®) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis
Duda, P. W., Schmied, M. C., Cook, S. L., Krieger, J. I., & Hafler, D. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8970 · Cited by 416
Testosterone Acts Directly on CD4+ T Lymphocytes to Increase IL-10 Production
Liva, S. M., & Voskuhl, R. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2060 · Cited by 395
Self-citation
Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis
McFarland, H. F., Frank, J. A., Albert, P. S., Smith, M. E., Martinꝉ, R., Harris, J. O., Patronas, N. J., Maloni, H. W., & McFarlin, D. E. (1992) · Annals of Neurology · doi:10.1002/ana.410320609 · Cited by 347

Show all 41 references

Sorted by citations

Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
The complex role of estrogens in inflammation
Straub, R. H. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0001 · Cited by 1,950
Gender differences in autoimmune disease
Ngo, S. T., Steyn, F. J., & McCombe, P. A. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.04.004 · Cited by 1,074
Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis
Robinson, D. P., & Klein, S. L. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.02.023 · Cited by 745
The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy
Offen, D., Gilgun-Sherki, Y., & Melamed, E. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0348-9 · Cited by 638
Sex Hormones in Acquired Immunity and Autoimmune Disease
Moulton, V. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02279 · Cited by 641
The cuprizone animal model: new insights into an old story
Kipp, M., Clarner, T., Dang, J., Copray, S., & Beyer, C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0591-3 · Cited by 481
Sex affects immunity
Pennell, L. M., Galligan, C. L., & Fish, E. N. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.11.013 · Cited by 412
Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations
Phiel, K. L., Henderson, R. A., Adelman, S. J., & Elloso, M. M. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.10.007 · Cited by 371
Estrogen anti-inflammatory activity in brain: A therapeutic opportunity for menopause and neurodegenerative diseases
Vegeto, E., Benedusi, V., & Maggi, A. C. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.04.001 · Cited by 364
A Starring Role for Microglia in Brain Sex Differences
Lenz, K. M., & McCarthy, M. M. (2015) · The Neuroscientist · doi:10.1177/1073858414536468 · Cited by 342
Immune Modulation in Multiple Sclerosis Patients Treated with the Pregnancy Hormone Estriol
Soldan, S. S., Retuerto, A. I. A., Sicotte, N. L., & Voskuhl, R. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6267 · Cited by 277
Self-citation
Sex-related factors in multiple sclerosis susceptibility and progression
Voskuhl, R. R., & Gold, S. M. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.43 · Cited by 262
Self-citation
Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration
Spence, R. D., & Voskuhl, R. R. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.12.001 · Cited by 259
Self-citation
Cell-specific and region-specific transcriptomics in the multiple sclerosis model: Focus on astrocytes
Itoh, N., Itoh, Y., Tassoni, A., Ren, E., Kaito, M., Ohno, A., Ao, Y., Farkhondeh, V., Johnsonbaugh, H., Burda, J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716032115 · Cited by 253
Self-citation
Estrogen as an immunomodulator
Lang, T. J. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.05.011 · Cited by 253
Impact of sex hormones on immune function and multiple sclerosis development
Ysrraelit, M. C., & Correale, J. D. (2018) · Immunology · doi:10.1111/imm.13004 · Cited by 272
Vitamin D3 Confers Protection from Autoimmune Encephalomyelitis Only in Female Mice
Spach, K. M., & Hayes, C. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.4119 · Cited by 251
Development of subtype-selective oestrogen receptor-based therapeutics
Nilsson, S. V., Koehler, K. F., & Gustafsson, J.-Å. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3551 · Cited by 256
Sex differences in autoimmune diseases
Voskuhl, R. R. (2011) · Biology of Sex Differences · doi:10.1186/2042-6410-2-1 · Cited by 251
Self-citation
The natural history of secondary progressive multiple sclerosis
Koch, M. W., Kingwell, E., Rieckmann, P., & Tremlett, H. L. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.208173 · Cited by 247
Cells of the oligodendroglial lineage, myelination, and remyelination
Miron, V. E., Kuhlmann, T., & Antel, J. P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.09.010 · Cited by 249
White Matter Plasticity and Enhanced Remyelination in the Maternal CNS
Gregg, C., Shikar, V., Larsen, P. H., Mak, G. K., Chojnacki, A. K., Yong, V. W., & Weiss, S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4441-06.2007 · Cited by 234
Estrogen Modulates Microglial Inflammatory Mediator Production via Interactions with Estrogen Receptor β
Baker, A. E., Brautigam, V. M., & Watters, J. J. (2004) · Endocrinology · doi:10.1210/en.2004-0619 · Cited by 227
Hormonal Effect on Psoriasis in Pregnancy and Post Partum
Murase, J. E., Chan, K. K., Garite, T. J., Cooper, D. M., & Weinstein, G. D. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.5.601 · Cited by 220
Estrogen Receptor α Signaling in T Lymphocytes Is Required for Estradiol-Mediated Inhibition of Th1 and Th17 Cell Differentiation and Protection against Experimental Autoimmune Encephalomyelitis
Lélu, K., Laffont, S., Delpy, L., Paulet, P.-E., Périnat, T., Tschanz, S. A., Pelletier, L., Engelhardt, B., & Guéry, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101578 · Cited by 211
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial
Voskuhl, R. R., Wang, H.-J., Wu, T. C. J., Sicotte, N. L., Nakamura, K., Kurth, F., Itoh, N., Bardens, J., Bernard, J. T., Corboy, J. R., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00322-1 · Cited by 206
Self-citation
Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders
Pinares-Garcia, P., Stratikopoulos, M., Zagato, A., Loke, H., & Lee, J. (2018) · Brain Sciences · doi:10.3390/brainsci8080154 · Cited by 200
Estrogen and testosterone therapies in multiple sclerosis
Gold, S. M., & Voskuhl, R. R. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17516-7 · Cited by 200
Self-citation
17β‐estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice
Ács, P., Kipp, M., Norkutė, A., Johann, S., Clarner, T., Braun, A., Berente, Z., Komoly, S., & Beyer, C. (2008) · Glia · doi:10.1002/glia.20806 · Cited by 194
Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions
Koning, N., Bö, L., Hoek, R. M., & Huitinga, I. (2007) · Annals of Neurology · doi:10.1002/ana.21220 · Cited by 186
The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis
Bove, R. M., & Chitnis, T. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458513519181 · Cited by 196
The importance of studying sex differences in disease: The example of multiple sclerosis
Golden, L. C., & Voskuhl, R. R. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23955 · Cited by 179
Self-citation
Role of gender in multiple sclerosis: Clinical effects and potential molecular mechanisms
Greer, J. M., & McCombe, P. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.03.003 · Cited by 165
Gender Differences in 1,25 Dihydroxyvitamin D3 Immunomodulatory Effects in Multiple Sclerosis Patients and Healthy Subjects
Correale, J. D., Ysrraelit, M. C., & Gaitán, M. I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000588 · Cited by 158
Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary
Lopez-Diego, R. S., & Weiner, H. L. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2358 · Cited by 154
Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis
Luchetti, S., Huitinga, I., & Swaab, D. F. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.010 · Cited by 164
Treatment with an Estrogen Receptor Ligand Is Neuroprotective in Experimental Autoimmune Encephalomyelitis
Morales, L. B. J., Loo, K. K., Liu, H.-B., Peterson, C., Tiwari-Woodruff, S. K., & Voskuhl, R. R. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0453-06.2006 · Cited by 149
Self-citation
Membrane Estrogen Receptor Regulates Experimental Autoimmune Encephalomyelitis through Up-regulation of Programmed Death 1
Wang, C., Dehghani, B., Li, Y., Kaler, L. J., Proctor, T., Vandenbark, A. A., & Offner, H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803205 · Cited by 148
Estradiol inhibits ongoing autoimmune neuroinflammation and NFκB-dependent CCL2 expression in reactive astrocytes
Giraud, S., Caron, C., Pham-Dinh, D., Kitabgi, P., & Nicot, A. (2010) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0910627107 · Cited by 147
The role of gender and organ specific autoimmunity
Nussinovitch, U., & Shoenfeld, Y. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.11.001 · Cited by 145
Estrogen Receptor α Mediates Estrogen’s Immune Protection in Autoimmune Disease
Liu, H.-B., Loo, K. K., Palaszynski, K. M., Ashouri, J. F., Lubahn, D. B., & Voskuhl, R. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6936 · Cited by 144
Self-citation
Estrogen and brain inflammation: Effects on microglial expression of MHC, costimulatory molecules and cytokines
Dimayuga, F. O., Reed, J. L., Carnero, G. A., Wang, C., Dimayuga, E. R., Smith, V. D., Perger, A., Wilson, M. E., Keller, J. N., & Bruce‐Keller, A. J. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.12.016 · Cited by 142
Estriol Generates Tolerogenic Dendritic Cells In Vivo That Protect against Autoimmunity
Papenfuss, T. L., Powell, N. D., McClain, M. A., Bedarf, A., Singh, A. J., Gienapp, I. E., Shawler, T. M., & Whitacre, C. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001322 · Cited by 144
Increase in multiple sclerosis activity after assisted reproduction technology
Correale, J., Farez, M. F., & Ysrraelit, M. C. (2012) · Annals of Neurology · doi:10.1002/ana.23745 · Cited by 134
Management of Multiple Sclerosis During Pregnancy and the Reproductive Years
Bove, R. M., Alwan, S. S., Friedman, J. M., Hellwig, K., Houtchens, M. K., Koren, G., Lu, E., McElrath, T. F., Smyth, P. S., Tremlett, H. L., et al. (2014) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000541 · Cited by 132
Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin‐17 production via programmed death 1
Wang, C., Dehghani, B., Li, Y., Kaler, L. J., Vandenbark, A. A., & Offner, H. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.03051.x · Cited by 129
Increased risk of multiple sclerosis relapse after in vitro fertilisation
Michel, L., Foucher, Y., Vukusic, S., Confavreux, C., Seze, J. D., Brassat, D., Clanet, M., Clavelou, P., Ouallet, J., Brochet, B., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302235 · Cited by 128
Fertility in patients with multiple sclerosis: current knowledge and future perspectives
Cavalla, P., Rovei, V., Masera, S., Vercellino, M., Massobrio, M., Mutani, R., & Revelli, A. (2006) · Neurological Sciences · doi:10.1007/s10072-006-0676-x · Cited by 127
Combination therapy in multiple sclerosis.
Conway, D. S., & Cohen, J. A. (2010) · Lancet Neurology · doi:10.1016/s1474-4422(10)70007-7 · Cited by 74
Long-term effects of childbirth in MS
D'hooghe, M. B., Nagels, G., & Uitdehaag, B. M. J. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.163816 · Cited by 122
Multiple sclerosis and pregnancy in the 'treatment era'
Vukusic, S., & Marignier, R. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.53 · Cited by 121
Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone
Gold, S. M., Chalifoux, S. L., Giesser, B. S., & Voskuhl, R. R. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-32 · Cited by 120
Self-citation
Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration
Chakrabarti, M., Haque, A., Banik, N., Nagarkatti, P., Nagarkatti, M., & Ray, S. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.09.004 · Cited by 119
The Pregnancy Pickle: Evolved Immune Compensation Due to Pregnancy Underlies Sex Differences in Human Diseases
Natri, H. M., García, A. R., Buetow, K. H., Trumble, B. C., & Wilson, M. A. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.04.008 · Cited by 118
Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells
The Finnish Multiple Sclerosis and Pregnancy Study Group, Airas, L. M., Saraste, M., Rinta, S., Elovaara, I., Huang, Y.-H., & Wiendl, H. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03555.x · Cited by 120
Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis
Palaszynski, K. M., Liu, H., Loo, K. K., & Voskuhl, R. R. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.12.015 · Cited by 116
Self-citation
Management of women with multiple sclerosis through pregnancy and after childbirth
Coyle, P. K. (2016) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285616631897 · Cited by 112
Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy
Engler, J. B., Kursawe, N., Solano, M. E., Patas, K., Wehrmann, S., Heckmann, N., Lühder, F., Reichardt, H. M., Arck, P., Gold, S. M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617115114 · Cited by 115
Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis
Kipp, M., & Beyer, C. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.004 · Cited by 116
Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis
Jolivel, V., Luessi, F., Masri, J., Kraus, S. H. P., Hubo, M., Poisa-Beiro, L., Klebow, S., Paterka, M., Yogev, N., Tumani, H., et al. (2013) · Brain · doi:10.1093/brain/awt023 · Cited by 108
Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands
Elloso, M. M., Phiel, K. L., Henderson, R. A., Harris, H. A., & Adelman, S. J. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06063 · Cited by 108
Sexual disparities in the incidence and course of MS
Bove, R. M., & Chitnis, T. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.03.005 · Cited by 116
Neuroprotective Role of Steroidal Sex Hormones: An Overview
Siddiqui, A. N., Siddiqui, N., Khan, R. A., Kalam, A., Jabir, N. R., Kamal, M., Firoz, C. K., & Tabrez, S. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12538 · Cited by 101
Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding
Voskuhl, R. R., & Momtazee, C. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0562-7 · Cited by 106
Self-citation
Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis
D'hooghe, M. B., Haentjens, P., Nagels, G., D’Hooghe, T., & Keyser, J. D. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6267-7 · Cited by 105
Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease
Ziehn, M. O., Avedisian, A., Dervin, S., Umeda, E., O'Dell, T., & Voskuhl, R. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2796-12.2012 · Cited by 98
Self-citation
Estrogen treatment in multiple sclerosis
Gold, S. M., & Voskuhl, R. R. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.05.028 · Cited by 107
Self-citation
A Potential Role for Estrogen in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
OFFNER, H., & POLANCZYK, M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1386.021 · Cited by 102
Evaluation of Endocrine Profile, Hypothalamic–Pituitary–Testis Axis and Semen Quality in Multiple Sclerosis
Safarinejad, M. R. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01791.x · Cited by 101
Th1/Th2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis
Al-Shammri, S., Rawoot, P., Azizieh, F. Y., Qoora, A. A., Hanna, M. G., Saminathan, T. R., & Raghupathy, R. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.03.027 · Cited by 100
Multiple functional therapeutic effects of the estrogen receptor β agonist indazole-Cl in a mouse model of multiple sclerosis
Moore, S. M., Khalaj, A. J., Kumar, S., Winchester, Z., Yoon, J., Yoo, T. S., Martinez‐Torres, L., Yasui, N., Katzenellenbogen, J. A., & Tiwari-Woodruff, S. K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411294111 · Cited by 101
Estrogen Facilitates Neurite Extension via Apolipoprotein E in Cultured Adult Mouse Cortical Neurons
Nathan, B. P., Barsukova, A. G., Shen, F., McAsey, M. E., & Struble, R. G. (2004) · Endocrinology · doi:10.1210/en.2003-1707 · Cited by 100
Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target
Arnold, S., & Beyer, C. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06133.x · Cited by 97
Gender and sex hormones in multiple sclerosis pathology and therapy
Nicot, A. B. (2009) · Frontiers in bioscience · doi:10.2741/3543 · Cited by 95
17beta‐estradiol protects oligodendrocytes from cytotoxicity induced cell death
Takao, T., Flint, N., Lee, L., Ying, X., Merrill, J., & Chandross, K. J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02370.x · Cited by 93
New approaches in the management of multiple sclerosis
Allington, D. R. (2010) · Drug Design Development and Therapy · doi:10.2147/dddt.s9331 · Cited by 92
Learning from Nature: Pregnancy Changes the Expression of Inflammation-Related Genes in Patients with Multiple Sclerosis
Gilli, F., Lindberg, R. L. P., Valentino, P., Marnetto, F., Malucchi, S., Sala, A., Capobianco, M. A. N., Sapio, A. D., Sperli, F., Kappos, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008962 · Cited by 89
Pregnancy, sex and hormonal factors in multiple sclerosis
Miller, D. H., Fazekas, F., Montalbán, X., Reingold, S. C., & Trojano, M. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458513519840 · Cited by 88
Sex bias in lymphocytes: Implications for autoimmune diseases
Dodd, K. C., & Menon, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.945762 · Cited by 96
Multiple sclerosis: Neuroprotective alliance of estrogen–progesterone and gender
Kipp, M., Amor, S., Krauth, R., & Beyer, C. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.01.001 · Cited by 86
Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system
Gonzalez, G. A., Hofer, M. P., Syed, Y. A., Amaral, A. I., Rundle, J., Rahman, S., Zhao, C., & Kotter, M. R. N. (2016) · Scientific Reports · doi:10.1038/srep31599 · Cited by 86
Pregnancy and multiple sclerosis: The children of PRIMS
Vukusic, S., & Confavreux, C. (2006) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2005.11.016 · Cited by 82
Pregnancy and multiple sclerosis: feto-maternal immune cross talk and its implications for disease activity
Patas, K., Engler, J. B., Friese, M. A., & Gold, S. M. (2013) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2012.10.005 · Cited by 82
Oral contraceptives combined with interferon β in multiple sclerosis
Pozzilli, C., Giglio, L. D., Barletta, V. T., Marinelli, F., Angelis, F. D., Gallo, V., Pagano, V. A., Marini, S., Piattella, M. C., Tomassini, V., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000120 · Cited by 82
Symptoms of multiple sclerosis in women in relation to sex steroid exposure
Holmqvist, P., Wallberg, M., Hammar, M. L., Landtblom, A., & Brynhildsen, J. (2005) · Maturitas · doi:10.1016/j.maturitas.2005.10.003 · Cited by 82
Estrogen Receptor α Signaling in Inflammatory Leukocytes Is Dispensable for 17β-Estradiol-Mediated Inhibition of Experimental Autoimmune Encephalomyelitis
Garidou, L., Laffont, S., Douin‐Echinard, V., Coureau, C., Krust, A., Chambon, P., & Guéry, J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2435 · Cited by 81
Age at onset of multiple sclerosis is correlated to use of combined oral contraceptives and childbirth before diagnosis
Holmqvist, P., Hammar, M. L., Landtblom, A., & Brynhildsen, J. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.06.045 · Cited by 81
NEUROPROTECTIVE AND ANTI-INFLAMMATORY EFFECTS OF ESTROGEN RECEPTOR LIGAND TREATMENT IN MICE
Tiwari-Woodruff, S., & Voskuhl, R. (2009) · Journal of Neurological Sciences · doi:10.1016/j.jns.2009.04.023 · Cited by 74
Self-citation
Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: Therapeutic implications for multiple sclerosis
Offner, H. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20330 · Cited by 80
Steroid hormones in multiple sclerosis
El‐Etr, M., Vukusic, S., Gignoux, L., Durand‐Dubief, F., Achiti, I., Baulieu, E. E., & Confavreux, C. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.004 · Cited by 79
The relapse rate of multiple sclerosis changes during pregnancy: a cohort study
Salemi, G., Callari, G., Gammino, M., Battaglieri, F., Cammarata, E., Cuccia, G., D’Amelio, M., Lupo, I., Ragonese, P., & Savettieri, G. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00270.x · Cited by 78
SeXX Matters in Multiple Sclerosis
Gilli, F., DiSano, K. D., & Pachner, A. R. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00616 · Cited by 79
Gender-related differences in MS: a study of conventional and nonconventional MRI measures
Antulov, R., Weinstock‐Guttman, B., Cox, J., Hussein, S. M., Durfee, J., Caiola, C., Dwyer, M. G., Bergsland, N., Abdelrahman, N. G., Stosic, M., et al. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508099479 · Cited by 79
17β-Estradiol Inhibits Class II Major Histocompatibility Complex (MHC) Expression: Influence on Histone Modifications and CBP Recruitment to the Class II MHC Promoter
Adamski, J., Ma, Z., Nozell, S. E., & Benveniste, E. N. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0098 · Cited by 76
Sex differences in a mouse model of multiple sclerosis: neuropathic pain behavior in females but not males and protection from neurological deficits during proestrus
Rahn, E. J., Iannitti, T., Donahue, R. R., & Taylor, B. K. (2014) · Biology of Sex Differences · doi:10.1186/2042-6410-5-4 · Cited by 76
Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERα)
Gold, S. M., Manda, S. V., Morales, L. B. J., Du, S., Sicotte, N. L., Tiwari-Woodruff, S. K., & Voskuhl, R. R. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.79 · Cited by 75
Self-citation
Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor‐mediated ERK1/2 activation to accelerate remyelination
Xiao, L., Guo, D., Hu, C., Shen, W., Shan, L., Li, C., Liu, X., Yang, W., Zhang, W., & He, C. (2012) · Glia · doi:10.1002/glia.22333 · Cited by 78
Gender and Estrogen Manipulation Do Not Affect Traumatic Brain Injury in Mice
Bruce‐Keller, A. J., Dimayuga, F. O., Reed, J. L., Wang, C., Angers, R. C., Wilson, M. E., Smith, V. D., & Scheff, S. W. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2006.0163 · Cited by 75
Gender Issues in Multiple Sclerosis
Schwendimann, R. N., & Alekseeva, N. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)79017-7 · Cited by 74

Authors: Sicotte, N. L., Liva, S. M., Klutch, R., Pfeiffer, P., Bouvier, S., Odesa, S., Wu, T. C. J., & Voskuhl, R. R.
Affiliations: University of California, Los Angeles (US)
Corresponding author: Voskuhl, Rhonda R.
ORCID: Sicotte, Nancy L.
Voskuhl, Rhonda R.
Venue: Annals of Neurology
Publisher: Wiley
Published: 2002-08-19
Volume: 52
Issue: 4
Pages: 421-428
ISSN: 0364-5134 (ISSN-L)
1531-8249
DOI: 10.1002/ana.10301
OpenAlex: W2135551891
Cited by: 435
References: 41
Citations by year: 2026: 7 · 2025: 8 · 2024: 10 · 2023: 13 · 2022: 13 · 2021: 9 · 2020: 14 · 2019: 12 · 2018: 22 · 2017: 11 · 2016: 24 · 2015: 19 · 2014: 30 · 2013: 25 · 2012: 30
FWCI: 12.95
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Annals of Neurology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords: multiple sclerosis, estriol, pregnancy hormones, relapsing-remitting multiple sclerosis, interferon-gamma, delayed-type hypersensitivity, gadolinium-enhancing lesions, disease-modifying therapy
MeSH terms: Adolescent, Adult, Estriol, Female, Humans, Hypersensitivity, Delayed, Magnetic Resonance Imaging, Middle Aged, Multiple Sclerosis, Pregnancy, Recurrence, Biomarkers, Th1 Cells, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Treatment of multiple sclerosis with the pregnancy hormone estriol

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks